Found 145 matching trials
Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab Versus Pembrolizumab Alone in Metastatic Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥ 50% (MK-2870-007) PHASE3 The primary objective of the study is to compare sacituzumab tirumotecan co...
Show More Location
Mayo Clinic in Arizona - Phoenix ( Site 0147)
Learn More & Join Trial
Allo HSCT Using RIC for Hematological Diseases PHASE2 This is a phase II trial using a non-myeloablative cyclophosphamide/ fludar...
Show More Location
Masonic Cancer Center at University of Minnesota
Learn More & Join Trial
Expanded Access Single Named Patient Program With Elotuzumab (BMS-901608) for the Treatment of Patient R-A With Relapsed/Refractory Multiple Myeloma N/A To provide elotuzumab treatment for single-patient use....
Status
No Longer Available
Location
Icahn School.of Medicine at Mount Sinai
Learn More & Join Trial
Belatacept to Prevent Organ Rejection in Kidney Transplant Patients PHASE2 Belatacept is an experimental medication shown in clinical trials to have i...
Show More Location
University of California, San Francisco
Learn More & Join Trial
Therapies for Down Syndrome Regression Disorder PHASE2 Individuals with Down syndrome (DS) have an increased risk of numerous co-o...
Show More Location
Children's Hospital Los Angeles
Learn More & Join Trial
Study Comparing Continuous Versus Fixed Duration Therapy With Daratumumab, Lenalidomide, and Dexamethasone for Relapsed Multiple Myeloma PHASE3 The incorporation of proteasome inhibitors and immunomodulatory drugs into ...
Show More Status
Active Not Recruiting
Location
Saint Antoine Hospital - Hematology Department
Learn More & Join Trial
Combination Immunosuppressive Therapy to Prevent Kidney Transplant Rejection in Adults PHASE1 Transplant rejection occurs when a patient's body does not recognize the ne...
Show More Location
University of Wisconsin - Department of Medicine
Learn More & Join Trial
A Phase II Study of Axicabtagene Ciloleucel, an Anti-CD19 Chimeric Antigen Receptor (CAR) Tcell Therapy, in Combination With Radiotherapy (RT) in Relapsed/Refractory Follicular Lymphoma PHASE2 To learn about the safety of a drug called axicabtagene ciloleucel given in...
Show More Location
MD Anderson Cancer Center
Learn More & Join Trial
A Clinical Trial of MK-1045 in People With B-cell Acute Lymphoblastic Leukemia (MK-1045-005) PHASE2 Researchers are looking for new ways to treat people with relapsed or refra...
Show More Location
Rigshospitalet ( Site 0802)
Learn More & Join Trial
A Study of Flurbiprofen 8.75 mg Lozenge in Patients With Pharyngitis PHASE3 The purposes of this study is to demonstrate the analgesic efficacy of flur...
Show More Location
Bluestone Center for Clinical Research
Learn More & Join Trial